[HTML][HTML] Transfusion-transmitted infections

F Bihl, D Castelli, F Marincola, RY Dodd… - Journal of translational …, 2007 - Springer
Although the risk of transfusion-transmitted infections today is lower than ever, the supply of
safe blood products remains subject to contamination with known and yet to be identified …

HIV-associated Kaposi sarcoma and related diseases

PH Gonçalves, TS Uldrick, R Yarchoan - Aids, 2017 - journals.lww.com
The search for the etiologic agent for Kaposi sarcoma led to the discovery of Kaposi
sarcoma-associated herpesvirus (KSHV) in 1994. KSHV, also called human herpesvirus-8 …

Emerging infectious disease agents and their potential threat to transfusion safety

SL Stramer, FB Hollinger, LM Katz, S Kleinman… - …, 2009 - Wiley Online Library
BACKGROUND: Emerging infections have been identified as a continuing threat to human
health. Many such infections are known to be transmissible by blood transfusion, while …

[HTML][HTML] Guidelines for the prevention and treatment of opportunistic infections among HIV-exposed and HIV-infected children: recommendations from CDC, the …

LM Mofenson, MT Brady, SP Danner… - MMWR Recomm …, 2009 - cdc.gov
This report updates and combines into one document earlier versions of guidelines for
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …

Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT

P Ljungman, R De La Camara, C Cordonnier… - Bone marrow …, 2008 - nature.com
These recommendations were prepared by the European Conference on Infections in
Leukaemia following a predefined methodology. Literature searches were made to identify …

Blood transfusion safety in sub‐Saharan Africa: a literature review of changes and challenges in the 21st century

A Weimer, CT Tagny, JB Tapko, C Gouws… - …, 2019 - Wiley Online Library
BACKGROUND Access to a safe, adequate blood supply has proven challenging in sub‐
Saharan Africa, where systemic deficiencies spanning policy, collections, testing, and …

Kaposi sarcoma–associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment

M Bhutani, MN Polizzotto, TS Uldrick, R Yarchoan - Seminars in oncology, 2015 - Elsevier
Kaposi sarcoma associated herpesvirus (KSHV), a γ2-herpesvirus, also known as human
herpesvirus-8, is the etiologic agent of three virally associated tumors: Kaposi sarcoma, a …

Kaposi sarcoma herpesvirus pathogenesis

G Mariggio, S Koch, TF Schulz - … Transactions of the …, 2017 - royalsocietypublishing.org
Kaposi sarcoma herpesvirus (KSHV), taxonomical name human gammaherpesvirus 8, is a
phylogenetically old human virus that co-evolved with human populations, but is now only …

Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges

EM Bloch, M Vermeulen, E Murphy - Transfusion medicine reviews, 2012 - Elsevier
Blood safety remains an important public health concern in Africa where lack of availability
or provision of unsafe blood adversely impacts morbidity and mortality in the region. In …

[HTML][HTML] KSHV LANA—the master regulator of KSHV latency

T Uppal, S Banerjee, Z Sun, SC Verma, ES Robertson - Viruses, 2014 - mdpi.com
Kaposi's sarcoma associated herpesvirus (KSHV), like other human herpes viruses,
establishes a biphasic life cycle referred to as dormant or latent, and productive or lytic …